Clinical data from Anacor?s tavaborole and AN2728 study to be presented at upcoming meetings Anacor Pharmaceuticals announced today that it will be presenting medical data on its business lead compounds, tavaborole and AN2728, at the following upcoming medical meetings: ?Security and Efficacy of AN2728 and AN2898 Ointments in a Stage 2a Bilateral Study of Mild-to-Moderate Atopic Dermatitis? 72nd Culture for Investigative Dermatology Annual Meeting – Thursday, May 10, 2012 Security and Efficacy of AN2728 and AN2898 Ointments in a Stage 2a Bilateral Study of Mild-to-Moderate Atopic Dermatitis 9th Australasian Society for Dermatology Research Meeting – Tuesday, May 22, 2012 Boron-structured AN2728 and AN2898 Ointments Demonstrate Safety and Efficacy in a Phase 2a Bilateral Study of Mild-to-Moderate Atopic Dermatitis American Podiatric Medical Association 2012 Annual Scientific Achieving friday – The National -, August 17, 2012 Protection and Efficacy of Tavaborole , a Novel Boron-Based Molecule,Â in Phase 2 Trials for the LOCALIZED TREATMENT of Toenail Onychomycosis American Academy of Dermatology Summertime Academy Meeting – Saturday 18 August, 2012 Regional Tolerability of AN2728 Topical Ointment, 2 percent in Sensitive Skin Areas Related StoriesAdvanced pneumatic compression device reduces cellulitis episodes, saves money for lymphedema patientsFirst extensive genomic and biologic study of top pores and skin disease-causing microbesLEO Pharma's Enstilar gets FDA acceptance for topical treatment of plaque psoriasis..Sometimes doctors take away the breast tumor in wish of prolonging survival also, but this has not really been place to a difficult test. Dr. Rajendra Badwe, director of the Tata Memorial Medical center in Mumbai, India, led a report of 350 ladies with spread cancers that experienced shrunk after initial chemotherapy broadly. Half received surgery to eliminate the breasts or the lump plus any cancerous lymph nodes. The others didn’t have surgery. After about 2 yrs, 40 % of both combined groups were alive, suggesting that medications are enough and these women could be spared the ordeal of experiencing all or component of a breasts removed.